Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis
Clinical trial NCT05019742 · TERMINATED
Trial details
- NCT number
- NCT05019742
- Sponsor
- Shanghai Pharma Biotherapeutics USA Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2022-11-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.